• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

碳青霉烯/舒巴坦合剂、多黏菌素、多黏菌素/利福平合剂及替加环素对耐碳青霉烯鲍曼不动杆菌的体外活性

In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.

作者信息

Song Joon Young, Kee Sae Yoon, Hwang In Sook, Seo Yu Bin, Jeong Hye Won, Kim Woo Joo, Cheong Hee Jin

机构信息

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.

出版信息

J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31.

DOI:10.1093/jac/dkm136
PMID:17540672
Abstract

OBJECTIVES

To determine the in vitro activities and interactions of imipenem, colistin and tigecycline with old antibacterial agents against carbapenem-resistant Acinetobacter baumannii.

METHODS

Forty-three carbapenem-resistant A. baumannii isolates from the intensive care unit of a university hospital were collected and their MICs of imipenem, colistin and tigecycline were determined. With eight randomly selected carbapenem-resistant isolates, an in vitro time-kill study was performed for the evaluation of antibacterial activity of colistin, tigecycline, imipenem/sulbactam and colistin/rifampicin.

RESULTS

The time-kill study of colistin demonstrated bactericidal activity against A. baumannii at concentrations of 4xMIC and 8xMIC, whereas tigecycline showed bacteriostatic activity at all concentrations. The combination regimens of imipenem/sulbactam and colistin/rifampicin were synergistic and bactericidal at 1xMIC.

CONCLUSIONS

Imipenem/sulbactam combination, colistin and tigecycline showed good in vitro activities against carbapenem-resistant A. baumannii isolates. Even though colistin is bactericidal against carbapenem-resistant A. baumannii, the colistin/rifampicin combination is more warranted in order to be certain.

摘要

目的

确定亚胺培南、黏菌素和替加环素与旧有抗菌药物对耐碳青霉烯鲍曼不动杆菌的体外活性及相互作用。

方法

收集某大学医院重症监护病房的43株耐碳青霉烯鲍曼不动杆菌分离株,测定其对亚胺培南、黏菌素和替加环素的最低抑菌浓度(MIC)。选取8株随机挑选的耐碳青霉烯分离株进行体外时间杀菌研究,以评估黏菌素、替加环素、亚胺培南/舒巴坦和黏菌素/利福平的抗菌活性。

结果

黏菌素的时间杀菌研究表明,在4倍MIC和8倍MIC浓度下对鲍曼不动杆菌具有杀菌活性,而替加环素在所有浓度下均显示抑菌活性。亚胺培南/舒巴坦和黏菌素/利福平联合用药方案在1倍MIC时具有协同杀菌作用。

结论

亚胺培南/舒巴坦联合用药、黏菌素和替加环素对耐碳青霉烯鲍曼不动杆菌分离株显示出良好的体外活性。尽管黏菌素对耐碳青霉烯鲍曼不动杆菌具有杀菌作用,但为确保疗效,黏菌素/利福平联合用药更有必要。

相似文献

1
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.碳青霉烯/舒巴坦合剂、多黏菌素、多黏菌素/利福平合剂及替加环素对耐碳青霉烯鲍曼不动杆菌的体外活性
J Antimicrob Chemother. 2007 Aug;60(2):317-22. doi: 10.1093/jac/dkm136. Epub 2007 May 31.
2
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.替加环素单独及与硫酸黏菌素或舒巴坦联合应用对从重症监护病房分离出的对碳青霉烯类敏感及耐药的鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2010 Aug;36(2):191-2. doi: 10.1016/j.ijantimicag.2010.04.004. Epub 2010 May 26.
3
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.黏菌素、利福平、亚胺培南和舒巴坦/氨苄西林单独或联合使用对产OXA-58碳青霉烯酶的流行多重耐药鲍曼不动杆菌分离株的比较活性。
Int J Antimicrob Agents. 2007 Dec;30(6):537-40. doi: 10.1016/j.ijantimicag.2007.07.007. Epub 2007 Sep 11.
4
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.单药治疗与联合抗生素治疗对免疫抑制小鼠模型中耐碳青霉烯类鲍曼不动杆菌肺炎的疗效
Int J Antimicrob Agents. 2009 Jan;33(1):33-9. doi: 10.1016/j.ijantimicag.2008.07.008. Epub 2008 Oct 2.
5
In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.米诺环素与黏菌素联合使用对耐亚胺培南鲍曼不动杆菌临床分离株的体外作用
J Antimicrob Chemother. 2007 Aug;60(2):421-3. doi: 10.1093/jac/dkm178. Epub 2007 May 31.
6
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.用于小鼠肺炎模型中耐碳青霉烯鲍曼不动杆菌引起的严重感染的抗生素联合用药
J Antimicrob Chemother. 2004 Dec;54(6):1085-91. doi: 10.1093/jac/dkh485. Epub 2004 Nov 16.
7
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.比较耐碳青霉烯类不动杆菌属种(鲍曼不动杆菌与 3 型和 13TU 型基因种)对抗菌药物组合的体外抗微生物药敏活性和协同作用。
Diagn Microbiol Infect Dis. 2011 Jul;70(3):380-6. doi: 10.1016/j.diagmicrobio.2011.03.003. Epub 2011 May 10.
8
In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii.各种抗菌药物单独及与替加环素联合应用对碳青霉烯类中介或耐药鲍曼不动杆菌的体外活性。
Antimicrob Agents Chemother. 2007 May;51(5):1621-6. doi: 10.1128/AAC.01099-06. Epub 2007 Feb 16.
9
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.黏菌素与替加环素或β-内酰胺类抗生素/β-内酰胺酶抑制剂组合对耐碳青霉烯类鲍曼不动杆菌的体外协同活性。
J Int Med Res. 2013 Dec;41(6):1830-7. doi: 10.1177/0300060513496172.
10
In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.黏菌素或舒巴坦与磷霉素或亚胺培南联合应用对产OXA-23碳青霉烯酶的耐碳青霉烯鲍曼不动杆菌临床分离株的体外活性。
Southeast Asian J Trop Med Public Health. 2011 Jul;42(4):890-900.

引用本文的文献

1
activity of sulbactam in combination with other antimicrobial agents against extensively drug-resistant .舒巴坦与其他抗菌药物联合使用对广泛耐药菌的活性。
Microbiol Spectr. 2025 Sep 2;13(9):e0137925. doi: 10.1128/spectrum.01379-25. Epub 2025 Aug 12.
2
The intricacies of : a multifaceted comprehensive review of a multidrug-resistant pathogen and its clinical significance and implications.……的复杂性:对一种多重耐药病原体及其临床意义和影响的多方面综合综述。 (注:原文开头部分不完整,翻译出来的句子也有部分成分缺失,不太能构成完整通顺的表述)
Front Microbiol. 2025 May 12;16:1565965. doi: 10.3389/fmicb.2025.1565965. eCollection 2025.
3
A microbiological and structural analysis of the interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of spp.
舒巴坦/度洛巴坦与亚胺培南对[具体菌种]青霉素结合蛋白(PBPs)相互作用的微生物学和结构分析
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0162724. doi: 10.1128/aac.01627-24. Epub 2025 Mar 4.
4
In vitro synergistic effects of mefloquine combined with other antimicrobial agents on carbapenem-resistant Enterobacterales.甲氟喹与其他抗菌药物联合应用对耐碳青霉烯类肠杆菌科细菌的体外协同作用
Eur J Clin Microbiol Infect Dis. 2025 May;44(5):1089-1097. doi: 10.1007/s10096-025-05060-5. Epub 2025 Feb 18.
5
Carbapenem resistance associated with coliuria among outpatient and hospitalised urology patients.门诊和住院泌尿外科患者中与菌尿相关的碳青霉烯类耐药性。
New Microbes New Infect. 2022 Aug 29;48:101019. doi: 10.1016/j.nmni.2022.101019. eCollection 2022 Jul.
6
Synergistic Antimicrobial Effect of Colistin in Combination with Econazole against Multidrug-Resistant Acinetobacter baumannii and Its Persisters.多黏菌素与依康唑联合应用对多重耐药鲍曼不动杆菌及其持续生存菌的协同抗菌作用。
Microbiol Spectr. 2022 Jun 29;10(3):e0093722. doi: 10.1128/spectrum.00937-22. Epub 2022 Apr 25.
7
Contemporary Perspective on the Treatment of Acinetobacter baumannii Infections: Insights from the Society of Infectious Diseases Pharmacists.鲍曼不动杆菌感染治疗的当代观点:来自传染病药师协会的见解
Infect Dis Ther. 2021 Dec;10(4):2177-2202. doi: 10.1007/s40121-021-00541-4. Epub 2021 Oct 14.
8
Bi-Functional Alginate Oligosaccharide-Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections.用于改善多重耐药革兰氏阴性菌感染治疗的双功能海藻酸寡糖-多粘菌素缀合物
Pharmaceutics. 2020 Nov 11;12(11):1080. doi: 10.3390/pharmaceutics12111080.
9
A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options.碳青霉烯类抗生素的细菌耐药性综述:流行病学、检测及治疗选择
Future Sci OA. 2020 Jan 27;6(3):FSO438. doi: 10.2144/fsoa-2019-0098.
10
Combined Rifampin and Sulbactam Therapy for Multidrug-Resistant Acinetobacter Baumannii Ventilator-Associated Pneumonia in Pediatric Patients.利福平与舒巴坦联合治疗儿童耐多药鲍曼不动杆菌呼吸机相关性肺炎
J Anesth Perioper Med. 2018 Jul;5(4):176-185. doi: 10.24015/JAPM.2018.0072.